Marex Group plc (MRX) Securities Class Action Lawsuit Filed [November 6, 2025]

Introduction to Marex Group plc (MRX) Securities Class Action Lawsuit

A securities fraud class action has been filed against Marex Group plc (NASDAQ: MRX) covering trades between May 16, 2024 and August 5, 2025. Investors allege the company touted strong financial performance while concealing self-dealing in over-the-counter instruments and inconsistencies in intercompany accounts that undermined the reliability of its financial statements. The complaint alleges that behind the upbeat releases and filings, Marex's accounting masked losses and risk through opaque related-party activity. On August 5, 2025, a third-party research report alleged a multi-year accounting scheme involving off-balance-sheet entities and fictitious intercompany transactions, contradicting the company's narrative. Following that disclosure, investors suffered losses as the stock declined on heavy volume.

Marex Group plc (MRX) Securities Lawsuit Case Details

Case Name: Narayanan v. Marex Group plc, et al.

Case No.: 1:25-cv-08393

Jurisdiction: U.S. District Court, Southern District of New York

Filed on: October 9, 2025

Marex Group plc (MRX) Company Profile

Marex is a global financial services firm providing liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets in the United Kingdom, the United States, and internationally. It operates across five segments—Clearing, Agency and Execution, Hedging and Investment Solutions, Corporate, and Market Making—and its corporate structure spans over 56 entities.

Marex Group plc (MRX) Securities Lawsuit Class Period

May 16, 2024–August 5, 2025, inclusive.

Eligible investors include all persons and entities that purchased or otherwise acquired Marex securities during the Class Period and who were damaged thereby and may be eligible to join the Marex Group plc (MRX) class action lawsuit. Excluded from the Class are Defendants, the officers and directors of the Company, at all relevant times, members of their immediate families and their legal representatives, heirs, successors, or assigns, and any entity in which Defendants have or had a controlling interest.

Allegations in the Marex Group plc (MRX) Securities Class Action Lawsuit

According to the complaint, Marex Group plc and senior executives Ian Lowitt and Robert Irvin told a consistent story of growth and strength throughout the class period. On May 16, 2024, the company announced full year 2023 results, stating "Performance was strong across the Group" with revenue up 75% to $1,245 million and profit before tax up 62% to $197 million. That same day, Marex published its UK Annual Report 2023, furnished to the SEC, highlighting that total equity increased 14% to $775.7 million driven by $141.3 million in profit after tax—figures presented as evidence of momentum.

During the following months, Marex continued to promote its trajectory. On August 14, 2024, a press release claimed "another period of strong performance," citing organic growth and benefits from acquisitions. On November 7, 2024, their third quarter 2024 results report said revenue "increased by over 100% to $52.0m in Q3 2024," attributing gains to metals trading. Investors allege these statements painted a picture of robust, reliable growth.

By early 2025, the company reinforced that narrative. On March 6, 2025, Marex announced "Record full year 2024 profit," with adjusted profit before tax up 40% to $321.1 million on a 28% revenue increase. On March 21, 2025, Marex filed its Form 20-F describing derivative assets and liabilities, while on April 2, 2025 CEO Ian Lowitt said the year had a "strong start" with "very robust" client activity. On May 15, 2025, the company reported first quarter 2025 revenue up 27% to $52.9 million, citing growth across asset classes and increased securities revenues. The complaint alleges that this stream of statements lacked a reasonable basis.

Plaintiffs contend that, throughout this period and leading up to the August 5, 2025 NINGI Research report, Marex failed to disclose that it sold over-the-counter financial instruments to itself and recorded inconsistent intercompany receivables and loans among subsidiaries and related parties. As alleged, these practices rendered Marex's financial statements unreliable, and the company's positive statements about its business, operations, and prospects were materially misleading.

The Truth Emerges

On August 5, 2025, NINGI Research published a report alleging that Marex engaged in a multi-year accounting scheme using a web of opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures to conceal significant losses, inflate profits, and mask true risk exposure. The report presented a comprehensive challenge to the integrity of Marex's reporting across the class period.

These revelations directly contradicted Marex's repeated claims of strong performance, steady profit growth, and reliable reporting in its press releases and SEC filings from May 16, 2024 through May 15, 2025. The complaint alleges that the NINGI report exposed systemic irregularities that undercut the company's prior narrative.

Market Reaction

On August 5, 2025, following the NINGI Research report, Marex's stock price fell $2.33, or 6.2%, to close at $35.31 per share on unusually heavy trading volume. For context within the class period, the company's share price had previously closed at a high of $48.33 per share on May 13, 2025.

Next Steps

• Submissions for lead plaintiff are due: December 8, 2025
• The Court will issue its order for lead plaintiff and counsel in the weeks after submissions are due.
• The Court will then consider motion for class certification.
• The Court will later consider a Motion to Dismiss.

To learn if you are eligible for recovery under the MRX securities class action lawsuit, visit the case submission page here.

Disclaimer: This shareholder alert is for informational purposes only and does not constitute legal advice. Consult a qualified attorney for personalized guidance. No specific outcomes are guaranteed. Note that this Shareholder Alert is based upon the second filed complaint, and not the first filed complaint. The first filed complaint is Michaella G. Katz v. Marex Group Plc, et al., Case No.: 1:25-cv-08368.